Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation

Circulation. 2020 Jun 2;141(22):1826-1828. doi: 10.1161/CIRCULATIONAHA.120.045826. Epub 2020 Jun 1.
No abstract available

Keywords: Alzheimer disease; Mendelian randomization analysis; atherosclerosis; heart valve diseases; lipoprotein(a); stroke.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / blood*
  • Alzheimer Disease / etiology
  • Causality
  • Cerebrovascular Disorders / blood*
  • Cerebrovascular Disorders / etiology
  • Coronary Disease / blood
  • Coronary Disease / etiology
  • Dementia, Vascular / blood
  • Dementia, Vascular / etiology
  • Heart Valve Diseases / blood*
  • Heart Valve Diseases / etiology
  • Humans
  • Lipoprotein(a) / blood*
  • Lipoprotein(a) / genetics
  • Mendelian Randomization Analysis
  • Odds Ratio
  • Polymorphism, Single Nucleotide
  • Thrombosis / blood*
  • Thrombosis / etiology
  • White People / genetics

Substances

  • Lipoprotein(a)